There were a lot of healthcare surprises this past year, and there are bound to be at least some in 2025 that take us by surprise. But that won’t stop us—or payers—from trying our darndest to plan ahead!
This year will bring a new presidential administration, new regulations, and new specialty drugs to market. And while no one has a crystal ball, Healthcare Brew asked a few executives at leading insurance and payer consultant companies what they predict might be on the horizon.
These answers have been lightly edited for length and clarity.
Sandhya Rao, chief medical officer, Blue Cross Blue Shield of Massachusetts
Prescription drug spending will continue to increase, especially driven by demand for high-cost brand drugs, like the GLP-1s for diabetes and weight loss. While these treatments are helping many of our members lead healthier lives, they are also increasing pharmaceutical costs. Our spending on these medications has risen by 250% over last year, putting us on track to spend nearly $200 million on these medications in 2024.
Keep reading here.—CC
|